3645 results for «714»
3645 results
Align for the future with next-generation balloon expandable transcatheter heart valve technology
14 May 2024 – From EuroPCR 2024
Tune in to this EuroPCR 2024 session to explore the Myval Octacor THV, a cutting-edge balloon-expandable transcatheter heart valve. Discover its advanced features, potential clinical benefits, and procedural impact. Learn about the latest updates on the Myval THV series and the LANDMARK RCT. Explore the OctaAlign technique for...
PCR's Got Talent - Round 1 - Session 1
14 May 2024 – From EuroPCR 2024
This session, comprising selected EuroPCR 2024 Abstract submissions, showcases a variety of research topics in the field of interventional cardiology. It includes presentations and discussions on sex differences in outcomes of percutaneous thrombectomy for pulmonary embolism, the validation of the MIRACLE2 score in OHCA patients, the...
Understanding how to use evidence in clinical practice
14 May 2024 – From EuroPCR 2024
This session focuses on understanding how to apply the latest evidence and clinical guidelines in daily practice for Non-Interventional Cardiologists (NAPs). It covers the influence of patient-reported outcomes on cardiovascular clinical practices, the translation of the 2023 ACS clinical guidelines into NAP's practice, the impact of...
Advancements in intracoronary imaging and intervention: unmasking vulnerable plaques and optimising durable PCI outcomes
16 May 2024 – From EuroPCR 2024
Delve into this EuroPCR 2024 session to gain insights into NIRS IVUS, exploring its applications, supported by current data, and understanding its clinical significance. Learn how to utilize NIRS IVUS in PCI planning through case examples, addressing lesion characteristics such as length and calcific nodules. Explore local...
Targeting inflammation in AMI: a debate
14 May 2024 – From EuroPCR 2024
Watch this session to explore inflammation's role in AMI, from atherosclerosis to post-infarct remodeling. Find out more about IL-6's significance in future MACE risk and cardiac status deterioration post-AMI, and delve into targeting inflammation via IL-6, evaluating short and long-term impacts.
Physiology guided post-DCB treatment to safely limit stenting. Validation in complex clinical settings with the optical Optowire III pressure guidewire
16 May 2024 – From EuroPCR 2024
Follow this session to discover how accurate resting index can inform decision-making for DCB in CTO patients and understand the role of physiology in a new PCI workflow for complex MVD. Thus, you will learn about a DCB intention-to-treat strategy guided by post-PCI coronary physiology in...
Advancing percutaneous treatment of pulmonary embolism with computer-assisted vacuum thrombectomy
14 May 2024 – From EuroPCR 2024
Join this session to delve into innovations in computer-assisted vacuum thrombectomy for acute pulmonary embolism, leveraging real-life case scenarios to share practical experiences and discuss treatment strategies. Amidst the current surge in scientific research, ongoing trials like STORM PE and STRIKE PE are pivotal in shaping...
Revisiting thrombus aspiration in STEMI with continuous power aspiration system
15 May 2024 – From EuroPCR 2024
Tune into this 2024 session for insights into the latest ESC guidelines, strategies to prevent and treat no reflow, and an examination of trials like TASTE, TAPAS, and TOTAL on coronary thrombus management. Explore also the outcomes of the CHEETAH study, pondering a potential paradigm shift,...
Treatment strategies of calcified lesions
14 May 2024 – From EuroPCR 2024
This session, comprising selected EuroPCR 2024 Abstract submissions, explores various treatment strategies for calcified coronary lesions. It includes presentations and discussions on the invasive evaluation of coronary artery compliance modification after intracoronary lithotripsy, a retrospective comparison of rotational atherectomy in NSTE-ACS and stable angina patients, the...
Expanding the indications of DCB for complex PCI scenarios
14 May 2024 – From EuroPCR 2024
This session, with the collaboration of various national societies, explores the use of drug-coated balloons (DCBs) in complex PCI scenarios, such as multivessel disease, left main, bifurcations, CTOs, or myocardial infarction. It includes case presentations and discussions on the procedural techniques, patient selection, and lesion preparation...
When and how to treat the side branch in non-left main bifurcations?
14 May 2024 – From EuroPCR 2024
Explore this video session covering essential techniques for handling bifurcations in coronary interventions. Learn to evaluate side branch significance and the need for a second stent, illustrated through three case studies. Discover main vessel stenting for a large side branch, various approaches like T-stenting, TAP, or...
Hotline: advances in coronary physiology
14 May 2024 – From EuroPCR 2024
This hotline session explores the latest advancements in coronary physiology and their implications for percutaneous coronary intervention (PCI). Topics covered include the influence of pathophysiological patterns of coronary artery disease on the safety and efficacy of PCI, the prognostic value of myocardial ischemic burden in STEMI...
Late-breaking trials: TAVI head-to-head
14 May 2024 – From EuroPCR 2024
This session presents the latest findings from several late-breaking trials comparing different transcatheter aortic valve implantation (TAVI) approaches. Topics include outcomes in women with small aortic annuli, the comparison of percutaneous versus surgical treatment for patients with aortic stenosis and coronary disease, the impact of valve...
Treatment strategies in complex coronary
14 May 2024 – From EuroPCR 2024
This session comprises a selection of complex coronary intervention cases from the EuroPCR 2024 Clinical Case submissions. The cases cover a range of challenging scenarios, including CTO with left ventricular dysfunction and VT storm, subintimal tracking and re-entry, and the decision between native vessel CTO PCI...
A new era for aortic regurgitation: how new guidelines and dedicated devices for AR will redefine treatment
18 Nov 2025 – From PCR London Valves 2025
This session examines the evolving treatment landscape for aortic regurgitation (AR) in light of new ESC guidelines and dedicated devices such as the JenaValve Trilogy System. It provides an in-depth look at refined diagnosis, optimized treatment strategies, and presents real-world data and clinical cases that highlight...
Advancing structural heart with 3D ICE and device guidance
17 Nov 2025 – From PCR London Valves 2025
This PCR London Valves 2025 session explores how 3D TEE, 3D intracardiac echocardiography (ICE), and DeviceGuide technology sharpen procedural accuracy, strengthen operator confidence, and streamline decision-making in real time.
You’ll see how clearly defined team roles enhance both safety and efficiency, and how thoughtful workflow integration can reduce...
Align for the future with next gen Myval transcatheter heart valve series
16 Nov 2025 – From PCR London Valves 2025
Discover how the latest Myval transcatheter heart valve (THV) innovations are shaping TAVI outcomes. This PCR London Valves 2025 session highlights the clinical evidence behind the next-gen Myval THV series, best practices for implantation, and upcoming innovations set to improve patient care. Learn step-by-step techniques for deploying Myval...
Cardiovalve hits the TARGET: advancing transcatheter valve replacement
18 Nov 2025 – From PCR London Valves 2025
This session highlights the features and procedural steps of the next-generation Cardiovalve systems for tricuspid and mitral valve replacement. It reviews interim results from the TARGET study, emphasizing echocardiographic findings and reverse remodeling effects, and discusses best practices for patient selection and the learning pathway to...
Cracking the tricuspid code "the Bicaval revolution"
16 Nov 2025 – From PCR London Valves 2025
This session decodes the advancement of caval valve therapy with the TricValve system, offering novel solutions for tricuspid regurgitation and right heart failure. It incorporates insights from clinical trials, real-world cases, and guideline integration, detailing imaging techniques and strategies for complex patient management including rescue interventions.
Day case TAVI - The future standard of care for most TAVI patients
16 Nov 2025 – From PCR London Valves 2025
Examining the UK experience, this session discusses the emerging standard of day case TAVI and its potential application across Europe. It evaluates patient-centered risks and benefits, operational requirements, and the evolving role of clinical valve coordinators to facilitate safe and efficient day case pathways for TAVI...
